Renal blood flow | |
---|---|
MeSH | D012079 |
In renal physiology, renal blood flow (RBF) is the volume of blood delivered to the kidneys per unit time. In humans, the kidneys together receive roughly 20 - 25% of cardiac output, amounting to 1.2 - 1.3 L/min in a healthy adult. [1] It passes about 94% to the cortex. RBF is closely related to renal plasma flow (RPF), which is the volume of blood plasma delivered to the kidneys per unit time.
Parameter | Value |
---|---|
renal blood flow | RBF = 1000 mL/min |
hematocrit | HCT = 40% |
glomerular filtration rate | GFR = 120 mL/min |
renal plasma flow | RPF = 600 mL/min |
filtration fraction | FF = 20% |
urine flow rate | V = 1 mL/min |
Sodium | Inulin | Creatinine | PAH |
---|---|---|---|
SNa = 150 mEq/L | SIn = 1 mg/mL | SCr = 0.01 mg/mL | SPAH = |
UNa = 710 mEq/L | UIn = 150 mg/mL | UCr = 1.25 mg/mL | UPAH = |
C Na = 5 mL/min | CIn = 150 mL/min | CCr = 125 mL/min | CPAH = 420 mL/min |
ER = 90% | |||
ERPF = 540 mL/min |
While the terms generally apply to arterial blood delivered to the kidneys, both RBF and RPF can be used to quantify the volume of venous blood exiting the kidneys per unit time. In this context, the terms are commonly given subscripts to refer to arterial or venous blood or plasma flow, as in RBFa, RBFv, RPFa, and RPFv. Physiologically, however, the differences in these values are negligible so that arterial flow and venous flow are often assumed equal.
Renal plasma flow | |
---|---|
MeSH | D017595 |
Renal plasma flow is the volume of plasma that reaches the kidneys per unit time. Renal plasma flow is given by the Fick principle:
This is essentially a conservation of mass equation which balances the renal inputs (the renal artery) and the renal outputs (the renal vein and ureter). Put simply, a non-metabolizable solute entering the kidney via the renal artery has two points of exit, the renal vein and the ureter. The mass entering through the artery per unit time must equal the mass exiting through the vein and ureter per unit time:
where Pa is the arterial plasma concentration of the substance, Pv is its venous plasma concentration, Ux is its urine concentration, and V is the urine flow rate. The product of flow and concentration gives mass per unit time.
As mentioned previously, the difference between arterial and venous blood flow is negligible, so RPFa is assumed to be equal to RPFv, thus
Rearranging yields the previous equation for RPF:
Values of Pv are difficult to obtain in patients. In practice, PAH clearance is used instead to calculate the effective renal plasma flow (eRPF). PAH (para-aminohippurate) is freely filtered, is not reabsorbed, and is secreted within the nephron. In other words, not all PAH crosses into the primary filtrate in Bowman's capsule and the remaining PAH in the vasa recta or peritubular capillaries is taken up and secreted by epithelial cells of the proximal convoluted tubule into the tubule lumen. In this way PAH, at low doses, is almost completely cleared from the blood during a single pass through the kidney. (Accordingly, the plasma concentration of PAH in renal venous blood is approximately zero.) Setting Pv to zero in the equation for RPF yields
which is the equation for renal clearance. For PAH, this is commonly represented as
Since the venous plasma concentration of PAH is not exactly zero (in fact, it is usually 10% of the PAH arterial plasma concentration), eRPF usually underestimates RPF by approximately 10%. This margin of error is generally acceptable considering the ease with which PAH infusion allows eRPF to be measured.
Finally, renal blood flow (RBF) can be calculated from a patient's renal plasma flow (RPF) and hematocrit (Hct) using the following equation:
If the kidney is methodologically perfused at moderate pressures (90–220 mm Hg performed on an experimental animal; in this case, a dog), then, there is a proportionate increase of:
-Renal Vascular Resistance
Along with the increase in pressure. At low perfusion pressures, Angiotensin II may act by constricting the efferent arterioles, thus mainlining the GFR and playing a role in autoregulation of renal blood flow. [3] People with poor blood flow to the kidneys caused by medications that inhibit angiotensin-converting enzyme may face kidney failure. [4]
Hemodynamics or haemodynamics are the dynamics of blood flow. The circulatory system is controlled by homeostatic mechanisms of autoregulation, just as hydraulic circuits are controlled by control systems. The hemodynamic response continuously monitors and adjusts to conditions in the body and its environment. Hemodynamics explains the physical laws that govern the flow of blood in the blood vessels.
Renal functions include maintaining an acid–base balance; regulating fluid balance; regulating sodium, potassium, and other electrolytes; clearing toxins; absorption of glucose, amino acids, and other small molecules; regulation of blood pressure; production of various hormones, such as erythropoietin; and activation of vitamin D.
Assessment of kidney function occurs in different ways, using the presence of symptoms and signs, as well as measurements using urine tests, blood tests, and medical imaging.
Vascular resistance is the resistance that must be overcome for blood to flow through the circulatory system. The resistance offered by the systemic circulation is known as the systemic vascular resistance or may sometimes be called by another term total peripheral resistance, while the resistance caused by the pulmonary circulation is known as the pulmonary vascular resistance. Vasoconstriction increases resistance, whereas vasodilation decreases resistance. Blood flow and cardiac output are related to blood pressure and inversely related to vascular resistance.
In the kidney, the macula densa is an area of closely packed specialized cells lining the wall of the distal tubule where it touches the glomerulus. Specifically, the macula densa is found in the terminal portion of the distal straight tubule, after which the distal convoluted tubule begins.
The Fick principle states that blood flow to an organ can be calculated using a marker substance if the following information is known:
In pharmacology, the volume of distribution is the theoretical volume that would be necessary to contain the total amount of an administered drug at the same concentration that it is observed in the blood plasma. In other words, it is the ratio of amount of drug in a body (dose) to concentration of the drug that is measured in blood, plasma, and un-bound in interstitial fluid.
In pharmacology, clearance is a pharmacokinetic parameter representing the efficiency of drug elimination. This is the rate of elimination of a substance divided by its concentration. The parameter also indicates the theoretical volume of plasma from which a substance would be completely removed per unit time. Usually, clearance is measured in L/h or mL/min. The quantity reflects the rate of drug elimination divided by plasma concentration. Excretion, on the other hand, is a measurement of the amount of a substance removed from the body per unit time. While clearance and excretion of a substance are related, they are not the same thing. The concept of clearance was described by Thomas Addis, a graduate of the University of Edinburgh Medical School.
Standardized Kt/V, also std Kt/V, is a way of measuring (renal) dialysis adequacy. It was developed by Frank Gotch and is used in the United States to measure dialysis. Despite the name, it is quite different from Kt/V. In theory, both peritoneal dialysis and hemodialysis can be quantified with std Kt/V.
In the physiology of the kidney, free water clearance (CH2O) is the volume of blood plasma that is cleared of solute-free water per unit time. An example of its use is in the determination of an individual's state of hydration. Conceptually, free water clearance should be thought of relative to the production of isoosmotic urine, which would be equal to the osmolarity of the plasma. If an individual is producing urine more dilute than the plasma, there is a positive value for free water clearance, meaning pure water is lost in the urine in addition to a theoretical isoosmotic filtrate. If the urine is more concentrated than the plasma, then free water is being extracted from the urine, giving a negative value for free water clearance. A negative value is typical for free water clearance, as the kidney usually produces concentrated urine except in the cases of volume overload by the individual.
Effective renal plasma flow (eRPF) is a measure used in renal physiology to calculate renal plasma flow (RPF) and hence estimate renal function.
The bicarbonate buffer system is an acid-base homeostatic mechanism involving the balance of carbonic acid (H2CO3), bicarbonate ion (HCO−
3), and carbon dioxide (CO2) in order to maintain pH in the blood and duodenum, among other tissues, to support proper metabolic function. Catalyzed by carbonic anhydrase, carbon dioxide (CO2) reacts with water (H2O) to form carbonic acid (H2CO3), which in turn rapidly dissociates to form a bicarbonate ion (HCO−
3 ) and a hydrogen ion (H+) as shown in the following reaction:
The multiple inert gas elimination technique (MIGET) is a medical technique used mainly in pulmonology that involves measuring the concentrations of various infused, inert gases in mixed venous blood, arterial blood, and expired gas of a subject. The technique quantifies true shunt, physiological dead space ventilation, ventilation versus blood flow ratios, and diffusion limitation.
In renal physiology, the filtration fraction is the ratio of the glomerular filtration rate (GFR) over the renal plasma flow (RPF).
The Alveolar–arterial gradient, is a measure of the difference between the alveolar concentration (A) of oxygen and the arterial (a) concentration of oxygen. It is a useful parameter for narrowing the differential diagnosis of hypoxemia.
Extraction ratio is a measure in renal physiology, primarily used to calculate renal plasma flow in order to evaluate renal function. It measures the percentage of the compound entering the kidney that was excreted into the final urine.
Para-aminohippurate (PAH) clearance is a method used in renal physiology to measure renal plasma flow, which is a measure of renal function.
In pharmacology, the elimination or excretion of a drug is understood to be any one of a number of processes by which a drug is eliminated from an organism either in an unaltered form or modified as a metabolite. The kidney is the main excretory organ although others exist such as the liver, the skin, the lungs or glandular structures, such as the salivary glands and the lacrimal glands. These organs or structures use specific routes to expel a drug from the body, these are termed elimination pathways:
The common raven, also known as the northern raven, is a large, all-black passerine bird. Found across the Northern Hemisphere, it is the most widely distributed of all corvids. Their Northern range encompasses Arctic and temperate regions of Eurasia and North America, and they reach as far South as Northern Africa and Central America. The common raven is an incredibly versatile passerine to account for this distribution, and their physiology varies with this versatility. This article discusses its physiology, including its homeostasis, respiration, circulatory system, and osmoregulation.
Positron emission tomography for bone imaging, as an in vivo tracer technique, allows the measurement of the regional concentration of radioactivity proportional to the image pixel values averaged over a region of interest (ROI) in bones. Positron emission tomography is a functional imaging technique that uses [18F]NaF radiotracer to visualise and quantify regional bone metabolism and blood flow. [18F]NaF has been used for imaging bones for the last 60 years. This article focuses on the pharmacokinetics of [18F]NaF in bones, and various semi-quantitative and quantitative methods for quantifying regional bone metabolism using [18F]NaF PET images.
{{cite book}}
: CS1 maint: multiple names: authors list (link){{cite book}}
: CS1 maint: multiple names: authors list (link)